QS Investors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

QS Investors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$336K	Buy	112,100 +400	+0.4%	+$1.27K	﹤0.01%	902
2021 Q1	$361K	Buy	111,700 +81,149	+266%	+$271K	﹤0.01%	914
2020 Q4	$65K	Hold	30,551	–	–	﹤0.01%	1156
2020 Q3	$36K	Sell	30,551 -119,949	-80%	-$123K	﹤0.01%	1157
2020 Q2	$137K	Hold	150,500	–	–	﹤0.01%	1227
2020 Q1	$127K	Hold	150,500	–	–	﹤0.01%	1196
2019 Q4	$159K	Sell	150,500 -3,050	-2%	-$3.35K	﹤0.01%	1241
2019 Q3	$159K	Hold	153,550	–	–	﹤0.01%	1262
2019 Q2	$277K	Sell	153,550 -3,600	-2%	-$5.8K	﹤0.01%	1129
2019 Q1	$296K	Hold	157,150	–	–	﹤0.01%	1123
2018 Q4	$186K	Sell	157,150 -1,757	-1%	-$3.16K	﹤0.01%	1150
2018 Q3	$431K	Hold	158,907	–	–	﹤0.01%	997
2018 Q2	$304K	Buy	158,907 +132	+0.1%	+$267	﹤0.01%	1075
2018 Q1	$333K	Sell	158,775 -14,005	-8%	-$30K	﹤0.01%	1041
2017 Q4	$351K	Sell	172,780 -9,600	-5%	-$19.9K	﹤0.01%	1027
2017 Q3	$243K	Hold	182,380	–	–	﹤0.01%	1156
2017 Q2	$286K	Hold	182,380	–	–	﹤0.01%	1083
2017 Q1	$589K	Hold	182,380	–	–	0.01%	916
2016 Q4	$246K	Hold	182,380	–	–	﹤0.01%	1062
2016 Q3	$285K	Hold	182,380	–	–	﹤0.01%	1023
2016 Q2	$243K	Hold	182,380	–	–	﹤0.01%	1060
2016 Q1	$961K	Hold	182,380	–	–	0.01%	781
2015 Q4	$1.43M	Hold	182,380	–	–	0.01%	727
2015 Q3	$1.54M	Hold	182,380	–	–	0.02%	690
2015 Q2	$2M	Hold	182,380	–	–	0.02%	620
2015 Q1	$2.55M	Buy	182,380 +104,130	+133%	+$1.59M	0.03%	539
2014 Q4	$1.32M	Buy	+78,250	New	+$1.14M	0.02%	667

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GPC

Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

QS Investors's INFI Position: Q2 2021 in Review

QS Investors increased its Infinity Pharmaceuticals, Inc. (INFI) stake by 0.36% in Q2 2021, buying an estimated $1.27K and bringing the position to 112,100 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

QS Investors first reported a position in INFI in Q4 2014 and has held it in 27 quarters since. The position peaked at $2.55M in Q1 2015. 97 funds tracked by Wall St. Rank hold INFI as of Q2 2021.

QS Investors held 112,100 shares of Infinity Pharmaceuticals, Inc. worth $336K as of Q2 2021.
QS Investors bought 400 Infinity Pharmaceuticals, Inc. shares in Q2 2021, an estimated $1.27K.
Infinity Pharmaceuticals, Inc. made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #902 holding.
QS Investors first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and has held it in 27 quarters since.
QS Investors's Infinity Pharmaceuticals, Inc. position peaked at $2.55M in Q1 2015.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.